Atlas Trials

Prognostic Value of Soluble Urokinase-type Plasminogen Activator Receptor in Valvular Heart Disease

Clinical trial NCT04571372 · COMPLETED

Trial details

NCT number
NCT04571372
Sponsor
Yonsei University
Status
COMPLETED
Study type
OBSERVATIONAL
Severe Aortic Stenosis or Severe Aortic Regurgitation
Start date
2020-08-14
Primary completion
2025-12-13
Enrollment
222

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.